Opendata, web and dolomites
H2020 projects about "oncogenic"
The page lists 69 projects related to the topic "oncogenic".
| # | |||
|---|---|---|---|
| 1 | CRCStemCellDynamics | Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers | 2015 |
| 2 | ONCORNET | ONCOgenic Receptor Network of Excellence and Training | 2015 |
| 3 | Cancer-Drug-Screen | High-throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient’s tumor | 2015 |
| 4 | RAGES | Molecular determination of Rif1-Associated Genomic Elements and their function in regulating genome activity and integrity | 2016 |
| 5 | KSHV QTV | Identification of novel KSHV immune evasion mechanisms using a quantitative temporal viromics analysis | 2015 |
| 6 | APOBEC | Enzymatic DNA deamination and the immunity/cancer balance | 2015 |
| 7 | SixthSense | Early diagnosis of cervical cancer through the validation of Human Papilloma Virus viral load and expression of oncogenic viral proteins E6/E7 as risk indicators | 2015 |
| 8 | SUMOblock | Blocking SUMO conjugation as drug discovery strategy. | 2015 |
| 9 | ONCOMECHAML | Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia | 2015 |
| 10 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 11 | ALKATRAS | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer | 2015 |
| 12 | M-Imm | Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells | 2015 |
| 13 | INFANTLEUKEMIA | GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OFINFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA | 2016 |
| 14 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 15 | HEP-CAR | Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | 2016 |
| 16 | CFS modelling | Chromosomal Common Fragile Sites: Unravelling their biological functions and the basis of their instability | 2016 |
| 17 | PrecTherLSCC | Precision Therapies in Lung Squamous Cell Carcinoma | 2016 |
| 18 | MECHANOCHECK | ATR-mediated mechanotransduction and connections with the actin cytoskeleton | 2016 |
| 19 | ONCOINTRABODY | Targeting common oncogenes with intracellular monobodies | 2016 |
| 20 | NanoSCAN | Developing multi-modality nanomedicines for targeted annotation of oncogenic signaling pathways | 2016 |
| 21 | TENSION | Targeting replication stress recovery pathways in oncology | 2016 |
| 22 | CancerFluxome | Cancer Cellular Metabolism across Space and Time | 2017 |
| 23 | BRECASTEM | Functional and Molecular Characterisation of Breast Cancer Stem Cells | 2017 |
| 24 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 25 | IVORIaN | RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer. | 2017 |
| 26 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
| 27 | SPLICANCER | Regulation and reprogramming of alternative splicing in cellular transformation | 2017 |
| 28 | DSMT16 | Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer | 2018 |
| 29 | ONCOGENEVOL | The evolutionary history of oncogenic and non-oncogenic papillomaviruses | 2017 |
| 30 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
| 31 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
| 32 | TarMyc | Targeting the Oncogenic Function of Myc in vivo | 2018 |
| 33 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 34 | CLLCLONE | Harnessing clonal evolution in chronic lymphocytic leukemia | 2018 |
| 35 | DiSect | The Tumour Stroma as a Driver of Clonal Selection | 2018 |
| 36 | GlycoSkin | Dissection of Glycan Function by Engineered Tissue Models | 2018 |
| 37 | SaveHER | The inhibition of sorting proteins as a therapeutic avenue in HER2 positive breast cancer | 2018 |
| 38 | ChemRAS | Chemical probing of transcriptional RAS effectors | 2019 |
| 39 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 40 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 41 | HiMIN | Histone H3.3 oncogenic mutations: a role in genome instability through altered DNA repair and replication fork stability? | 2018 |
| 42 | ProMeta | Non-histone protein acetylation targets of KAT2A in AML | 2018 |
| 43 | TRANSREG | Dissecting the role of Translational Regulation in Tumorigenesis | 2018 |
| 44 | HPV OncoPredict | A Groundbreaking Stand-Alone Diagnostic Kit to Predict Human Papilloma Virus Infections Evolving into Cervical Cancer | 2018 |
| 45 | TARGETSS | Targeting SWI/SNF complex function in cancer | 2019 |
| 46 | INTEGRATA | Integrating chemical and biological approaches to target NAD production and signaling in cancer | 2018 |
| 47 | FIRM | Form and Function of the Mitochondrial Retrograde Response | 2019 |
| 48 | Oncogenic PI3-kinase | New biology of oncogenic PI 3-kinase | 2019 |
| 49 | Kinaddict | Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. | 2019 |
| 50 | EOBRECA | Differential Roles of Estrogens in Obesity-mediated ER+ Breast Cancer Development | 2019 |
| 51 | INTEGRIN REGULATION | Functional analysis of the kinome and phosphatome as determinants of integrin phosphorylation in cancer | 2019 |
| 52 | IEOCCD | THE IMPACT OF THE ENVIRONMENT AND ONCOGENESIS ON CANCER CELL DIVISIONS | 2019 |
| 53 | MechTransition | Regulatory mechanisms controlling a new mechanical Epithelial to Mesenchymal Transition in zebrafish | 2020 |
| 54 | POLAR STAR | Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer | 2019 |
| 55 | MONET | Merkel cell polyomavirus Oncogenic Network | 2019 |
| 56 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 57 | EPICAN | Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer | 2020 |
| 58 | ONCOTECT | Early detection of tumor DNA in liquid biopsies as a biomarker of cancer recurrence | 2019 |
| 59 | Breakborder | Breaking borders, Functional genetic screens of structural regulatory DNA elements | 2019 |
| 60 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
| 61 | T-NHL SUPRESSORS | Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma | 2019 |
| 62 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 63 | ONCORNET2.0 | ONCOgenic Receptor Network of Excellence and Training 2.0 | 2020 |
| 64 | ONco-Energetics_OFF | Dissection of Bioenergetic Plasticity of Tumors | 2020 |
| 65 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |
| 66 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 67 | NOSCAR | decipheriNg Oncogenic SIgnalling patterns to break CAncer drug Resistance | 2020 |
| 68 | TETCOLON | Dissecting the role of the epigenetic regulator TET2 in colorectal cancer | 2020 |
| 69 | Catenin-Condensation | The effect of β-catenin condensation on the Wnt-pathway | 2020 |